Career Shifts: From Academia To Industry, And Vice Versa

In 1986, after 30 years with Merck Sharp & Dohme Research Laboratories, chemist T.Y. Shen took an early retirement. But he wasn't settling down to a life of leisure. After a successful career in industry, Shen wanted to take a stab at becoming an academic scientist. I enjoyed my career at Merck very much, first in research and later in administration, he says. But I wanted to do more research and enjoy an academic life in a second career. As Shen's experience shows, just because a scientis

Written byLisa Simon
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

In 1986, after 30 years with Merck Sharp & Dohme Research Laboratories, chemist T.Y. Shen took an early retirement. But he wasn't settling down to a life of leisure. After a successful career in industry, Shen wanted to take a stab at becoming an academic scientist. I enjoyed my career at Merck very much, first in research and later in administration, he says. But I wanted to do more research and enjoy an academic life in a second career.

As Shen's experience shows, just because a scientist starts on a career in industry does not mean that he won't ever be able to start a new career in academia. And the reverse is true, too. Many scientists who have successfully made these major career moves report that the transition can be made smoothly and that the switch has helped to rectify what they believed were gaps in their work experience.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies